Ageism Costs Billions in Health Care Dollars
THURSDAY, Nov. 15, 2018 -- Prejudice directed at older people results in $63 billion in excess health costs each year in the United States, a new study claims.
Ageism, which is the marginalization of the elderly in society, accounts for one of every seven dollars spent on the eight most expensive health conditions for Americans older than 60. Those conditions include heart disease, chronic respiratory disease and mental health disorders.
The researchers also found that ageism was linked with 17 million cases of those eight health conditions in one year.
"Ageism is one of the least visible prejudices," said study author Becca Levy, a professor at the Yale University School of Public Health.
"Our study helps to increase the visibility of ageism by looking at its consequences," she added in a Yale news release.
The study was published online Nov. 13 in the journal The Gerontologist.
"Our findings make a strong case for efforts aimed at reducing the epidemic of ageism, which produces not only a financial cost for society, but also a human cost for the well-being of older persons," Levy said.
In previous research, Levy and colleagues found that ageism harms the health of seniors because it can create stress, which affects many types of health outcomes.
© 2020 HealthDay. All rights reserved.
Posted: November 2018
Read this next
FRIDAY, Oct. 23, 2020 -- Active older adults -- cancer survivors included -- are in better physical and mental health than their sedentary peers, a new study finds. More regular...
FRIDAY, Oct. 23, 2020 -- Kids growing up in poverty show the effects of being poor as early as age 5 -- especially those who are Black, a new study suggests. The research adds to...
TUESDAY, Oct. 20, 2020 -- Marijuana is fast becoming a favorite medication among older Americans, a new study finds. Cannabis is being used to ease problems such as pain, sleep...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.